Behind the Scenes
OUR holly springs FACILITY
Our 700,000 sq. ft. manufacturing facility in Holly Springs, North Carolina will support our pharma division’s next-generation metabolic medicines portfolio, including treatments for obesity, ultimately helping to deliver life-changing science to patients.
This state-of-the art facility represents a $700+ million investment in the United States with potential expansion in the future. Stay in touch as construction continues!
This state-of-the art facility represents a $700+ million investment in the United States with potential expansion in the future. Stay in touch as construction continues!
WORK IN PROGRESS
Take a look at our latest site milestones!
Set to be operational by 2029, our expanded $2 billion plant will leverage advanced automation and digital tools to boost efficiency and sustainability while significantly expanding Genentech’s U.S.-based supply chain.
Set to be operational by 2029, our expanded $2 billion plant will leverage advanced automation and digital tools to boost efficiency and sustainability while significantly expanding Genentech’s U.S.-based supply chain.
Our new facility near Raleigh, North Carolina, an established biopharmaceutical talent hub, will serve as an important new setting within our manufacturing network to help deliver on the promise of our company’s life-changing science and industry-leading pipeline. We are thrilled to establish this relationship with the city of Holly Springs, where we expect to have a positive impact on the local economy and community, as we have across the United States since we pioneered the biotech industry nearly 50 years ago.
Ashley Magargee
Genentech CEO
